GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹273 Cr | ₹293 Cr | ₹222 Cr | ₹192 Cr | ₹205 Cr |
What is the latest Sundry Debtors ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹273 Cr |
| Mar2025 | ₹293 Cr |
| Mar2024 | ₹222 Cr |
| Mar2023 | ₹192 Cr |
| Mar2022 | ₹205 Cr |
How is Sundry Debtors of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹273 Cr | -6.64 | |
| Mar2025 | ₹293 Cr | 31.75 | |
| Mar2024 | ₹222 Cr | 15.43 | |
| Mar2023 | ₹192 Cr | -6.27 | |
| Mar2022 | ₹205 Cr | - | |
Compare Sundry Debtors of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹45,628.7 Cr | -1.2% | 5% | 5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -1.2% |
5% |
5.7% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses